Back
NuScale Rises 9.2% Despite Sell Rating and $750M Equity Plan
Back
Stock News
Themes
NuScale Rises 9.2% Despite Sell Rating and $750M Equity Plan
NuScale Rises 9.2% Despite Sell Rating and $750M Equity Plan
Edgen Stock
·
Jan 12 2026, 04:14
Share to
Share to
Copy link
SMR
-3.24%
source:
[1] What Catalysts Are Rewriting The NuScale Power (SMR) Story For Wall Street?
Recommend
Agriculture ETFs Break Out on Fertilizer Supply Fears
Mar 06 2026, 16:17
Tango Therapeutics Stock Hits Record High on Erasca Cancer Trial Deal
Mar 06 2026, 16:02
Parker-Hannifin Stock Climbs 53% on Aerospace Demand
Mar 06 2026, 16:01
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved